Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (211-220 of 382) with videos related to

Pageof 39
Sort By:
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
Cancer|May 13, 2008
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment GroupDavid J Inwards, Paul A S Fishkin, David W Hillman, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary Pseudomyogenic Hemangioendothelioma of BoneAlero Inyang, Fredrik Mertens, Florian Puls, et al.
Transplantation and Cellular Therapy|June 6, 2021
Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control StudyLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
British Journal of Haematology|April 8, 1998
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantationA Palmas, A Tefferi, J L Myers, et al.
The Lancet. Oncology|March 29, 2011
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 studyStephen M Ansell, Hui Tang, Paul J Kurtin, et al.
Hematological Oncology|June 5, 2018
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphomaCarrie A Thompson, Kathleen J Yost, Matthew J Maurer, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2025
Young Adult and Adolescent Gender-affirming Care: Defining Perioperative ProtocolsCaitlyn C Belza, Gaby Sendek, Miriam Becker, et al.
Pageof 39

Showing results (211-220 of 382) with videos related to

Sort By:
Pageof 39
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
Cancer|May 13, 2008
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment GroupDavid J Inwards, Paul A S Fishkin, David W Hillman, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary Pseudomyogenic Hemangioendothelioma of BoneAlero Inyang, Fredrik Mertens, Florian Puls, et al.
Transplantation and Cellular Therapy|June 6, 2021
Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control StudyLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
British Journal of Haematology|April 8, 1998
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantationA Palmas, A Tefferi, J L Myers, et al.
The Lancet. Oncology|March 29, 2011
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 studyStephen M Ansell, Hui Tang, Paul J Kurtin, et al.
Hematological Oncology|June 5, 2018
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphomaCarrie A Thompson, Kathleen J Yost, Matthew J Maurer, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2025
Young Adult and Adolescent Gender-affirming Care: Defining Perioperative ProtocolsCaitlyn C Belza, Gaby Sendek, Miriam Becker, et al.
Pageof 39